首頁 > 市場調查報告書 > 醫療設備

e保健遠距離醫療

市場調查報告書

商品編碼

2023905

遠端醫療市場預測至2034年－全球分析（按組成部分、模式、交付方式、類型、應用、最終用戶和地區分類）

Telemedicine Market Forecasts to 2034 - Global Analysis By Component (Products, and Services), Modality, Delivery Mode, Type, Application, End User, and By Geography

出版日期: 2026年04月17日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計到 2026 年，全球遠端醫療市場規模將達到 1,188 億美元，並在預測期內以 21.9% 的複合年成長率成長，到 2034 年將達到 5,795 億美元。

遠端醫療是指利用通訊技術遠端提供醫療服務，使患者無需與醫護人員面對面接觸即可進行諮詢、診斷、監測和治療。該市場涵蓋廣泛的應用，包括線上諮詢、遠端患者監護、影像資料儲存和傳輸以及行動醫療干預。數位基礎設施的快速發展、智慧型手機普及率的不斷提高以及患者對便捷醫療服務的偏好不斷變化，正在從根本上改變全球都市區地區的醫療服務提供方式。

擴大服務不足地區獲得醫療保健服務的機會。

在偏遠地區和醫生短缺的地區，遠端照護正日益成為彌合醫療保健差距的切實可行的解決方案。在農村社區，患者往往需要花費數小時才能獲得專科醫療服務，而將患者與都市區專家聯繫起來的線上諮詢服務正發揮著至關重要的作用。在醫療基礎設施有限的開發中國家，遠端醫療平台正在被推廣應用，以在無需大規模投資建設實體醫療機構的情況下擴大基層醫療服務的覆蓋範圍。在政府推動數位醫療公平和擴大行動網路覆蓋範圍的措施的推動下，這種普及速度正在加快。醫療保健服務的民主化是已開發經濟體和新興經濟體永續市場成長的最強勁驅動力之一。

贖回和監管的碎片化

各司法管轄區之間缺乏統一的支付政策，持續為考慮投資遠端醫療的醫療服務提供者帶來財務不確定性。雖然一些地區已建立有利的報銷框架，但其他地區仍維持限制性政策，將遠端醫療的應用範圍限制在特定疾病或病患群體。跨州執業許可要求進一步加劇了服務提供的複雜性，因為醫療服務提供者在為執業管轄區以外的患者提供治療時，必須遵守不同的法規。在某些市場，疫情期間推出的臨時報銷彈性措施的到期也帶來了更大的不確定性。因此，一些醫療機構正在推遲擴張計劃，直到永久性政策訂定，這阻礙了它們充分發揮市場成長潛力。

與穿戴式醫療設備的整合

互聯連線健診設備正在為遠端醫療開闢新的可能性，使其超越簡單的問診，邁向預防性和持續性護理管理。能夠檢測心房顫動的智慧型手錶、可將即時數據傳輸給醫生的連續血糖監測儀以及支援藍牙功能的血壓監測儀，正在產生前所未有的海量患者健康數據。整合這些資料流的遠端醫療平台使醫療服務提供者能夠在患者症狀嚴重之前及早識別並干預病情，從而減少住院次數。這種從被動、間歇性護理向預防性遠端監測的轉變，在慢性病管理、術後後續觀察和老年護理方面創造了巨大的價值，並為先進的遠距遠端醫療解決方案開闢了至關重要的發展路徑。

資料安全和隱私漏洞

醫療服務的快速數位化正在擴大網路犯罪分子攻擊的目標，他們的目標是高度敏感的患者資訊。處理敏感健康資料的遠端醫療平台必須遵守諸如 HIPAA 等嚴格法規，但小規模的醫療機構往往缺乏資源來實施強力的網路安全措施。視訊會議漏洞、資料儲存不足以及針對醫療系統的勒索軟體攻擊正在削弱某些市場的患者信任。大規模資料外洩導致醫療記錄被盜和服務中斷，造成聲譽損害和法律責任。隨著遠距遠端醫療的普及，安全漏洞造成的經濟和聲譽損失仍然是對市場穩定和消費者信任的持續威脅。

新冠疫情的影響：

新冠疫情以前所未有的速度推動了遠端醫療的普及，原本需要十年才能完成的流程，在短短幾個月內就得以實現。封鎖、保持社交距離的呼籲以及對醫療機構內病毒傳播的擔憂，迫使全球醫療系統迅速部署遠距會診功能。監管障礙暫時解除，報銷政策擴大，醫護人員和病患都迫於無奈開始熟悉遠距醫療。這場「被迫試驗」證明了遠端醫療在眾多領域（從基層醫療到心理健康服務）的有效性。其深遠影響在於，遠距醫療的使用標準得到了永久性提升，許多患者和醫護人員即使在疫情限制解除後，也會選擇繼續使用遠距醫療來應對合適的症狀。

在預測期內，基於雲端的細分市場預計將成為最大的細分市場。

預計在預測期內，基於雲端的遠距醫療解決方案將佔據最大的市場佔有率，這主要得益於其擴充性、較低的前期成本以及與現有醫療IT基礎設施的無縫整合。雲端平台使醫療服務提供者能夠快速部署遠端醫療功能，而無需投資昂貴的本地伺服器或僱用專門的IT人員進行維護。自動化的軟體更新確保了符合不斷變化的安全標準和監管要求。雲端解決方案能夠應對從日常諮詢到疫情引發的就診高峰等各種患者數量的波動，這使得它對尋求營運柔軟性的醫療系統尤為具有吸引力。此外，基於雲端的分析工具能夠提供有關人群健康的寶貴見解，從而鞏固該細分市場在整個預測期內的市場主導地位。

預計在預測期內，行動醫療醫療（行動醫療）領域將呈現最高的複合年成長率。

在預測期內，行動醫療）領域預計將呈現最高的成長率，這主要得益於智慧型手機的普及和以健康為中心的行動應用程式的激增。患者越來越傾向於透過熟悉的行動介面而非專用入口網站或桌面平台獲取醫療服務，從而實現隨時隨地獲得醫療服務。行動應用程式現在支援視訊諮詢、處方箋管理、檢測結果檢視、症狀檢查等功能，所有這些都整合在一個直覺的用戶體驗中。與智慧型手機感測器和穿戴式裝置的整合進一步增強了行動醫療在遠端監測和預防醫學方面的能力。隨著5G網路在全球範圍內的擴展，行動連線更快、更可靠，行動醫療解決方案預計將在所有人群中實現爆發式成長。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這得益於其先進的醫療保健IT基礎設施、有利的報銷政策以及智慧型手機的高普及率。面對醫生短缺和人口老化等嚴峻的醫療保健服務挑戰，美國正積極採用遠端醫療來控制成本並擴大服務範圍。在後疫情時代，主要保險公司和政府計畫（如聯邦醫療保險）已永久擴大了虛擬醫療的覆蓋範圍。領先的遠端醫療平台供應商的存在以及創業投資投資對數位醫療Start-Ups的大力投入，進一步加速了創新和應用。這些結構性優勢確保北美在整個預測期內保持其領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於該地區龐大的人口基數和有限的醫療資源、快速普及的行動網際網路以及政府主導的數位醫療舉措。印度、中國和舉措等國正在利用遠端醫療來解決嚴重的醫病比例問題，尤其是在醫療基礎設施仍然薄弱的農村地區。印度的「eSanjeevani」和中國的「網路醫院」等國家級計畫正在迅速擴展，為數百萬民眾提供遠距醫療諮詢服務。智慧型手機和資料方案的普及，以及慢性病負擔的日益加重，正在催生對便利醫療服務的持續需求。隨著支持遠端醫療的法律規範日益完善，亞太地區正在崛起為成長最快的區域市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要企業進行SWOT分析（最多3家公司）
區域細分
- 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第12章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第13章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第14章：公司簡介

Teladoc Health, Inc.
Amwell
MDLIVE Inc.
Doctor On Demand, Inc.
GlobalMed
MeMD
PlushCare
HealthTap, Inc.
98point6 Inc.
Babylon Healthcare Services Ltd
Practo Technologies Pvt. Ltd.
Ping An Good Doctor
Maple Corporation
KRY International AB
DocPlanner Group

簡介目錄圖表

Product Code: SMRC35116

According to Stratistics MRC, the Global Telemedicine Market is accounted for $118.8 billion in 2026 and is expected to reach $579.5 billion by 2034 growing at a CAGR of 21.9% during the forecast period. Telemedicine refers to the remote delivery of healthcare services using telecommunications technology, enabling consultations, diagnoses, monitoring, and treatment without physical patient-provider interaction. This market encompasses a wide spectrum of applications including virtual doctor visits, remote patient monitoring, store-and-forward imaging, and mobile health interventions. The rapid expansion of digital infrastructure, increasing smartphone penetration, and shifting patient preferences toward convenient healthcare access are fundamentally transforming how medical services are delivered across both urban and rural populations worldwide.

Market Dynamics:

Driver:

Expanding healthcare access in underserved regions

Remote populations and areas with physician shortages are increasingly turning to telemedicine as a practical solution for bridging healthcare gaps. Rural communities, where specialty care often requires hours of travel, benefit tremendously from virtual consultations that connect patients with urban-based specialists. Developing nations with limited healthcare infrastructure are adopting telemedicine platforms to extend primary care reach without massive capital investments in brick-and-mortar facilities. Government initiatives promoting digital health equity, combined with improving mobile network coverage, are accelerating adoption. This democratization of healthcare access represents one of the most powerful forces driving sustained market expansion across both developed and emerging economies.

Restraint:

Reimbursement and regulatory fragmentation

Inconsistent payment policies across jurisdictions continue to create financial uncertainty for healthcare providers considering telemedicine investments. While some regions have established favorable reimbursement frameworks, others maintain restrictive policies limiting virtual care coverage to specific conditions or patient populations. Cross-state licensing requirements for physicians further complicate service delivery, as providers must navigate varying regulations when treating patients outside their licensed jurisdictions. The expiration of temporary pandemic-era reimbursement flexibilities in certain markets has introduced additional unpredictability, causing some healthcare organizations to delay expansion plans until permanent policies are established, thereby restraining the market's full growth potential.

Opportunity:

Integration with wearable medical devices

Connected health devices are opening new frontiers for telemedicine beyond simple consultations into proactive, continuous care management. Smartwatches capable of detecting atrial fibrillation, continuous glucose monitors transmitting real-time data to physicians, and Bluetooth-enabled blood pressure cuffs are generating unprecedented volumes of patient-generated health data. Telemedicine platforms integrating these data streams enable providers to identify deteriorating conditions before symptoms become severe, intervene earlier, and reduce hospital admissions. This shift from reactive episodic care to proactive remote monitoring creates substantial value for chronic disease management, post-surgical follow-up, and elderly care, representing a significant growth avenue for sophisticated telemedicine solutions.

Threat:

Data security and privacy vulnerabilities

The rapid digitization of healthcare delivery has expanded the attack surface for cybercriminals targeting sensitive patient information. Telemedicine platforms handling protected health information must comply with stringent regulations like HIPAA, yet smaller providers often lack resources for robust cybersecurity measures. Video conferencing vulnerabilities, insecure data storage, and ransomware attacks on healthcare systems have eroded patient confidence in certain markets. High-profile data breaches resulting in stolen medical records or disrupted services generate negative publicity and legal liabilities. As telemedicine adoption grows, the financial and reputational consequences of security failures present ongoing threats to market stability and consumer trust.

Covid-19 Impact:

The COVID-19 pandemic triggered an unprecedented acceleration in telemedicine adoption, compressing what might have taken a decade into mere months. Lockdowns, social distancing requirements, and fears of virus exposure in clinical settings forced healthcare systems worldwide to rapidly deploy virtual care capabilities. Regulatory barriers were temporarily lifted, reimbursement policies expanded, and both providers and patients developed comfort with remote consultations out of necessity. This forced experiment demonstrated telemedicine's effectiveness across numerous specialties, from primary care to mental health services. The lasting legacy is a permanently elevated baseline of utilization, with many patients and providers choosing to continue virtual care for appropriate conditions long after pandemic restrictions ended.

The Cloud-Based segment is expected to be the largest during the forecast period

The Cloud-Based segment is expected to account for the largest market share during the forecast period, driven by its scalability, lower upfront costs, and seamless integration with existing healthcare IT infrastructure. Cloud platforms enable healthcare providers to rapidly deploy telemedicine capabilities without investing in expensive on-premise servers or dedicated IT personnel for maintenance. Automatic software updates ensure compliance with evolving security standards and regulatory requirements. The ability to handle fluctuating patient volumes, from routine consultations to pandemic surges, makes cloud solutions particularly attractive for health systems seeking operational flexibility. Additionally, cloud-based analytics tools provide valuable population health insights, reinforcing this segment's dominant market position throughout the forecast timeline.

The mHealth (Mobile Health) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the mHealth (Mobile Health) segment is predicted to witness the highest growth rate, fueled by the near-ubiquitous presence of smartphones and the proliferation of health-focused mobile applications. Patients increasingly prefer accessing healthcare services through familiar mobile interfaces rather than dedicated portals or desktop platforms, enabling anytime, anywhere care delivery. Mobile apps now support video consultations, prescription management, lab result access, and symptom checking, all within intuitive user experiences. Integration with smartphone sensors and wearable devices further enhances mHealth capabilities for remote monitoring and preventive care. As 5G networks expand globally, enabling faster, more reliable mobile connections, mHealth solutions are positioned for exceptional growth across all demographic groups.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced healthcare IT infrastructure, favorable reimbursement policies, and high smartphone adoption rates. The United States, facing significant healthcare access challenges including physician shortages and an aging population, has aggressively embraced telemedicine as a cost-containment and access-expansion tool. Major insurance providers and government programs like Medicare have permanently expanded virtual care coverage post-pandemic. The presence of leading telemedicine platform vendors and strong venture capital investment in digital health startups further accelerates innovation and deployment. These structural advantages ensure North America maintains its leadership position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by massive underserved populations, rapid mobile internet penetration, and government digital health initiatives. Countries including India, China, and Indonesia are leveraging telemedicine to address severe doctor-to-patient ratios, particularly in rural areas where healthcare infrastructure remains limited. National programs like India's eSanjeevani and China's internet hospitals are scaling rapidly, providing millions of citizens with remote access to medical consultations. The proliferation of affordable smartphones and data plans, combined with rising chronic disease burdens, creates sustained demand for convenient healthcare access. As regulatory frameworks mature to support cross-state telemedicine, Asia Pacific emerges as the fastest-growing regional market.

Key players in the market

Some of the key players in Telemedicine Market include Teladoc Health, Inc., Amwell, MDLIVE Inc., Doctor On Demand, Inc., GlobalMed, MeMD, PlushCare, HealthTap, Inc., 98point6 Inc., Babylon Healthcare Services Ltd, Practo Technologies Pvt. Ltd., Ping An Good Doctor, Maple Corporation, KRY International AB, and DocPlanner Group.

Key Developments:

In February 2026, MDLIVE announced a 24-hour guarantee for virtual dermatology consultations across all 50 U.S. states, leveraging its expanded network of board-certified specialists to meet rising demand for non-urgent skin care.

In January 2026, Amwell successfully went live with Blue Cross Blue Shield of Florida, integrating its virtual care technology into the payer's member portal to serve millions of covered lives.

In May 2025, Teladoc launched its "Global Care" initiative, streamlining virtual cross-border consultations for multinational employers, specifically targeting the European and Asia-Pacific markets.

Components Covered:

Products
Services

Modalities Covered:

Real-Time (Synchronous)
Store-and-Forward (Asynchronous)
Remote Patient Monitoring
Hybrid Telemedicine

Delivery Modes Covered:

Web-Based
Cloud-Based
On-Premise

Types Covered:

Tele-Hospitals
Tele-Homes
mHealth (Mobile Health)

Applications Covered:

Teleradiology
Telecardiology
Teledermatology
Telepathology
Telepsychiatry
Tele-Oncology
Tele-Neurology
Tele-ICU
Other Applications

End Users Covered:

Healthcare Facilities
Homecare Settings
Ambulatory Care Centers
Payers & Employers
Other End Users

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Telemedicine Market, By Component

5.1 Products
- 5.1.1 Hardware
- 5.1.2 Software
5.2 Services
- 5.2.1 Tele-Consultation
- 5.2.2 Tele-Diagnosis
- 5.2.3 Tele-Monitoring
- 5.2.4 Tele-Education
- 5.2.5 Support & Maintenance

6 Global Telemedicine Market, By Modality

6.1 Real-Time (Synchronous)
6.2 Store-and-Forward (Asynchronous)
6.3 Remote Patient Monitoring
6.4 Hybrid Telemedicine

7 Global Telemedicine Market, By Delivery Mode

7.1 Web-Based
7.2 Cloud-Based
7.3 On-Premise

8 Global Telemedicine Market, By Type

8.1 Tele-Hospitals
8.2 Tele-Homes
8.3 mHealth (Mobile Health)

9 Global Telemedicine Market, By Application

9.1 Teleradiology
9.2 Telecardiology
9.3 Teledermatology
9.4 Telepathology
9.5 Telepsychiatry
9.6 Tele-Oncology
9.7 Tele-Neurology
9.8 Tele-ICU
9.9 Other Applications

10 Global Telemedicine Market, By End User

10.1 Healthcare Facilities
- 10.1.1 Hospitals
- 10.1.2 Clinics
10.2 Homecare Settings
10.3 Ambulatory Care Centers
10.4 Payers & Employers
10.5 Other End Users

11 Global Telemedicine Market, By Geography

11.1 North America
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
11.2 Europe
- 11.2.1 United Kingdom
- 11.2.2 Germany
- 11.2.3 France
- 11.2.4 Italy
- 11.2.5 Spain
- 11.2.6 Netherlands
- 11.2.7 Belgium
- 11.2.8 Sweden
- 11.2.9 Switzerland
- 11.2.10 Poland
- 11.2.11 Rest of Europe
11.3 Asia Pacific
- 11.3.1 China
- 11.3.2 Japan
- 11.3.3 India
- 11.3.4 South Korea
- 11.3.5 Australia
- 11.3.6 Indonesia
- 11.3.7 Thailand
- 11.3.8 Malaysia
- 11.3.9 Singapore
- 11.3.10 Vietnam
- 11.3.11 Rest of Asia Pacific
11.4 South America
- 11.4.1 Brazil
- 11.4.2 Argentina
- 11.4.3 Colombia
- 11.4.4 Chile
- 11.4.5 Peru
- 11.4.6 Rest of South America
11.5 Rest of the World (RoW)
- 11.5.1 Middle East
  - 11.5.1.1 Saudi Arabia
  - 11.5.1.2 United Arab Emirates
  - 11.5.1.3 Qatar
  - 11.5.1.4 Israel
  - 11.5.1.5 Rest of Middle East
- 11.5.2 Africa
  - 11.5.2.1 South Africa
  - 11.5.2.2 Egypt
  - 11.5.2.3 Morocco
  - 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives

14 Company Profiles

14.1 Teladoc Health, Inc.
14.2 Amwell
14.3 MDLIVE Inc.
14.4 Doctor On Demand, Inc.
14.5 GlobalMed
14.6 MeMD
14.7 PlushCare
14.8 HealthTap, Inc.
14.9 98point6 Inc.
14.10 Babylon Healthcare Services Ltd
14.11 Practo Technologies Pvt. Ltd.
14.12 Ping An Good Doctor
14.13 Maple Corporation
14.14 KRY International AB
14.15 DocPlanner Group

簡介目錄圖表

List of Tables

Table 1 Global Telemedicine Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Telemedicine Market Outlook, By Component (2023-2034) ($MN)
Table 3 Global Telemedicine Market Outlook, By Products (2023-2034) ($MN)
Table 4 Global Telemedicine Market Outlook, By Hardware (2023-2034) ($MN)
Table 5 Global Telemedicine Market Outlook, By Software (2023-2034) ($MN)
Table 6 Global Telemedicine Market Outlook, By Services (2023-2034) ($MN)
Table 7 Global Telemedicine Market Outlook, By Tele-Consultation (2023-2034) ($MN)
Table 8 Global Telemedicine Market Outlook, By Tele-Diagnosis (2023-2034) ($MN)
Table 9 Global Telemedicine Market Outlook, By Tele-Monitoring (2023-2034) ($MN)
Table 10 Global Telemedicine Market Outlook, By Tele-Education (2023-2034) ($MN)
Table 11 Global Telemedicine Market Outlook, By Support & Maintenance (2023-2034) ($MN)
Table 12 Global Telemedicine Market Outlook, By Modality (2023-2034) ($MN)
Table 13 Global Telemedicine Market Outlook, By Real-Time (Synchronous) (2023-2034) ($MN)
Table 14 Global Telemedicine Market Outlook, By Store-and-Forward (Asynchronous) (2023-2034) ($MN)
Table 15 Global Telemedicine Market Outlook, By Remote Patient Monitoring (2023-2034) ($MN)
Table 16 Global Telemedicine Market Outlook, By Hybrid Telemedicine (2023-2034) ($MN)
Table 17 Global Telemedicine Market Outlook, By Delivery Mode (2023-2034) ($MN)
Table 18 Global Telemedicine Market Outlook, By Web-Based (2023-2034) ($MN)
Table 19 Global Telemedicine Market Outlook, By Cloud-Based (2023-2034) ($MN)
Table 20 Global Telemedicine Market Outlook, By On-Premise (2023-2034) ($MN)
Table 21 Global Telemedicine Market Outlook, By Type (2023-2034) ($MN)
Table 22 Global Telemedicine Market Outlook, By Tele-Hospitals (2023-2034) ($MN)
Table 23 Global Telemedicine Market Outlook, By Tele-Homes (2023-2034) ($MN)
Table 24 Global Telemedicine Market Outlook, By mHealth (Mobile Health) (2023-2034) ($MN)
Table 25 Global Telemedicine Market Outlook, By Application (2023-2034) ($MN)
Table 26 Global Telemedicine Market Outlook, By Teleradiology (2023-2034) ($MN)
Table 27 Global Telemedicine Market Outlook, By Telecardiology (2023-2034) ($MN)
Table 28 Global Telemedicine Market Outlook, By Teledermatology (2023-2034) ($MN)
Table 29 Global Telemedicine Market Outlook, By Telepathology (2023-2034) ($MN)
Table 30 Global Telemedicine Market Outlook, By Telepsychiatry (2023-2034) ($MN)
Table 31 Global Telemedicine Market Outlook, By Tele-Oncology (2023-2034) ($MN)
Table 32 Global Telemedicine Market Outlook, By Tele-Neurology (2023-2034) ($MN)
Table 33 Global Telemedicine Market Outlook, By Tele-ICU (2023-2034) ($MN)
Table 34 Global Telemedicine Market Outlook, By Other Applications (2023-2034) ($MN)
Table 35 Global Telemedicine Market Outlook, By End User (2023-2034) ($MN)
Table 36 Global Telemedicine Market Outlook, By Healthcare Facilities (2023-2034) ($MN)
Table 37 Global Telemedicine Market Outlook, By Hospitals (2023-2034) ($MN)
Table 38 Global Telemedicine Market Outlook, By Clinics (2023-2034) ($MN)
Table 39 Global Telemedicine Market Outlook, By Homecare Settings (2023-2034) ($MN)
Table 40 Global Telemedicine Market Outlook, By Ambulatory Care Centers (2023-2034) ($MN)
Table 41 Global Telemedicine Market Outlook, By Payers & Employers (2023-2034) ($MN)
Table 42 Global Telemedicine Market Outlook, By Other End Users (2023-2034) ($MN)